The Human Genome Project: How Private Sector Developments Affect the Government Program [Hearing Charter; Statement of Dr. Ari Patrinos, Associate Director, Office of Biological and Environmental Research, Office of Energy Research, Department of Energy; Statement of Dr. J. Craig Venter, President and Director, The Institute for Genomic Research; Statement of Dr. Francis S. Collins, Director, National Human Genome Research Institute; Statement of Dr. David J. Galas, President and Chief Scientific Officer, Chiroscience R & D Inc.; Testimony of Dr. Maynard V. Olson]
United States. Congress. House. Committee on Science. Subcommittee on Energy and Environment
Unpublished documents. Testimony before the Subcommittee 1998 June 17; [multiple pages]
Showing items related by title, author, creator and subject.
Stem Cell Research: Patenting and Health Implications: Testimony of Maria C. Freire, Ph.D., Director, National Institutes of Health Office of Technology Transfer [Hearing of the Subcommittee on Labor, Health and Human Service, and Education, Committee on Appropriations, U.S. Senate. 26 January 1999] Freire, Maria C. (1999-02)
Combating Terrorism: Chemical and Biological Medical Supplies Are Poorly Managed. Statement of Cynthia A. Bascetta, Associate Director Veterans' Affairs and Military Health Care Issues, Health, Education, and Human Services Division. Testimony Before the Subcommittee on National Security, Veterans Affairs, and International Relations, Committee on Government Reform, House of Representatives Unknown creator (United States. General Accounting Office [GAO], 2000-03-08)
Health Care Access: Programs for Underserved Populations Could Be Improved. Statement of Janet Heinrich, Associate Director Health Financing and Public Health Issues, Health Education, and Human Services Division. Testimony Before The Subcommittee on Public Health and Safety, Committee on Health, Education, Labor and Pensions, U.S. Senate Unknown creator (United States. General Accounting Office [GAO], 2000-03-23)